MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today ...
There is a small organ sitting behind your breastbone, roughly the size of a walnut in adults, that most physicians have ...
Living tissues do not change through biology alone. They are shaped by a constant dialogue among forces, chemicals, and ...
Cash and cash equivalents of $10.2 million as of March 31, 2026 Favorable efficacy and safety reported in a small sample of triple negative breast cancer ("TNBC") ...
When the body encounters infection or cancer, cytotoxic T lymphocytes attach to the affected cell and form the immune synapse ...
Creativity and curiosity have always been central to the work of Joshua Moreau, Ph.D., an immunologist whose work at Oregon ...
Organ transplantation remains the cornerstone treatment for end-stage organ failure. While conventional broad-spectrum immunosuppression effectively controls acute rejection, it fails to address ...
The molecule cAMP, which plays essential roles in mammalian cells, is less well understood in plants. In a new Science ...